Meeting
2019 ASCO Quality Care Symposium
Novel clinical definitions for immune-related adverse events (irAEs): A QI intervention to improve accuracy in irAE diagnosis.
Authors
Amanda Brito
Dana-Farber Cancer Institute, Boston, MA
Amanda Brito, Shilpa Grover, Raja-Elie E Abdulnour, PRABHSIMRANJOT SINGH, Eric Yenulevich, Kenneth L. Kehl, Jian Ni, Nicole R. LeBoeuf, Joseph O. Jacobson, Osama E. Rahma
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Patient Experience; Safety; Technology and Innovation in Quality of Care
Track
Patient Experience,Technology and Innovation in Quality of Care,Safety
Sub Track
Tools for Management of Treatment and Adverse Effects
Citation
J Clin Oncol 37, 2019 (suppl 27; abstr 290)
DOI
10.1200/JCO.2019.37.27_suppl.290
Abstract #
290
Poster Bd #
J3
Abstract Disclosures
Similar Posters
Poster
2017 ASCO-SITC Clinical Immuno-Oncology Symposium
Experience of immune-related adverse events associated with ipilimumab and nivolumab in a single center.
First Author: Bernardo Leon Rapoport
Poster
2024 ASCO Annual Meeting
Detection of immune-related adverse events among hospitalized patients using large language models.
First Author: Virginia H. Sun
Poster
2024 ASCO Annual Meeting
Early combination with mycophenolate mofetil for immune-related hepatitis in patients with solid tumors treated with immune checkpoint inhibitors.
First Author: Yukiko Shimoda Igawa
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Immune-related adverse events in patients with gastrointestinal cancer undergoing pembrolizumab monotherapy: A systematic review of clinical trials.
First Author: Nikolas Naleid